Month: March 2022

Surrozen Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

On Track to Initiate Phase 1 Clinical Trials in Healthy Volunteers for SZN-1326 and SZN-043 in the Third Quarter of 2022 SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a corporate update. “Surrozen’s significant achievements in 2021 have prepared us to transition to a clinical-stage biotechnology company as we drive toward multiple key milestones in 2022,” said Craig Parker, President and Chief Executive Officer of Surrozen. “We are on track to advance our lead therapeutic candidates, SZN-1326 and SZN-043, into the clinic in the...

Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2021 and Provides Corporate Update

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

Building Momentum with Completion of Patient Enrollment in 4 Late-Stage Trials Multiple Late-Stage Clinical Trial Data Catalysts in 2022:– Nyxol® MIRA-3 Phase 3 Results Expected End of 1Q 2022– MIRA-4 Pediatric, and LYNX-1 Phase 3 Results Expected to follow in 2Q 2022– ZETA-1 Phase 2 Diabetic Retinopathy Results Expected in 2H 2022 NDA Filing for Nyxol in Reversal of Mydriasis Planned for Late 2022 with Potential Launch as First Dilation Reversal Drop in 2H 2023 Plans to Initiate VEGA Phase 3 FDA Registration Trials for Nyxol Alone and in Combination with Low-Dose Pilocarpine (LDP) in Presbyopia in Mid-2022 FARMINGTON HILLS, Mich., March 24, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of...

ContraFect Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Update

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

Phase 3 DISRUPT study enrollment continues on course towards conducting interim futility analysis as anticipated in H1 2022 YONKERS, N.Y., March 24, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announces business updates and financial results for the fourth quarter and full year ended December 31, 2021. “Most importantly, we are on track and continue to expect to conduct the planned interim futility analysis based on approximately 60% of the MRSA study population by the end of the first half of 2022. Unlike other analyses for non-inferiority, this analysis...

Gain Therapeutics, Inc. Reports Full Year 2021 Financial Results and Business Update

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

$36.88 Million in cash as of December 31, 2021, provides runway into second half of 2023 and a strong cash position to transition the Company’s lead program into clinical trials —Compelling preclinical data presented on lead program GBA1 Parkinson’s Disease at multiple scientific conferences supports transition to clinical stage company with FIH trial by year end — Entered into multi-target deal with Zentalis Pharmaceuticals to identify novel small molecules for oncology indications BETHESDA, Md., March 24, 2022 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding sites that have never been targeted in neurodegenerative diseases and lysosomal storage disorders, today announced its financial results for...

Luckin Coffee Inc. Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

Fourth Quarter Net Revenues Grew More than 80%; Fiscal Year 2021 Net Revenues up Nearly 100% Opened 353 Net New Stores in Fourth Quarter; One of The Largest Coffee Networks in China with More than 6,000 Stores Achieved 20.9% Store Level Profit for Self-Operated Stores in Fourth Quarter Successful Conclusion of Provisional Liquidation BEIJING, March 24, 2022 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced its unaudited financial results for the three months ended December 31, 2021 and fiscal year 2021. COMPANY STATEMENT “We are very pleased to report strong overall performance in the fourth quarter and fiscal year 2021,” said Dr. Jinyi Guo, Chairman and Chief Executive Officer of Luckin Coffee. “We opened more than 350 net new stores during the quarter and are one of the largest...

WarpSpeed Taxi Inc (WRPT) Monthly Update with a Signed USA Licensing Agreement, Five-Year Plan and Beta Testing

Written by Customer Service on March 24, 2022. Posted in Public Companies.

LAS VEGAS, NV, March 24, 2022 (GLOBE NEWSWIRE) — WarpSpeed Taxi Inc. (OTC Pink: WRPT) (“WarpSpeed” or the “Company”), the developer of an all-in-one software solution for ride-hailing, food delivery, and courier services, is excited to update its shareholders with breaking news over the last month. On March 16, 2022 The Company announced it had signed an Agreement with a U.S.-based joint venture partner (the “US Partner”) to launch ride-hailing and delivery operations in the United States using the Company’s feature-rich, white-label software platform. The US Partner has agreed to contribute $1 million in stages by December 31, 2022 in order to drive the launch of operations in return for access to the WarpSpeed Taxi platform and 50% ownership of the venture. The initial launch is planned for October 2022 in Nevada, with expansion...

Form 8.3 – Mckay Securities – Amended 23/03/2022

Written by Customer Service on March 24, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Investec Wealth & Investment Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeMcKay Securities(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Dynacor Declares April 2022 Monthly Dividend

Written by Customer Service on March 24, 2022. Posted in Dividend Reports And Estimates.

MONTREAL, March 24, 2022 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG) (Dynacor or the Corporation) announced its monthly dividend. The declaration of a dividend payment of C$0.0083 per common share will be payable on April 19, 2022, to shareholders of record as of the close of business on April 8, 2022. This dividend represents the twenty-fifth (25th) dividend and (15th) fifteenth monthly payment made to shareholders. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. ABOUT DYNACOR Dynacor is a dividend-paying industrial gold ore processor headquartered in Montreal,...

Heating, Ventilation, and Cooling (HVAC) System Market to Exhibit 5.3% CAGR from 2022 to 2029; Smart Systems to Gain Traction in North America: Fortune Business Insights™

Written by Customer Service on March 24, 2022. Posted in Mergers And Acquisitions.

Companies Profiled in the HVAC System Market Report: Johnson Controls (Ireland), DAIKIN INDUSTRIES, Ltd. (Japan), Lennox International Inc. (U.S.), Carrier (U.S.), Mitsubishi Electric Corporation (Japan), Nortek Global HVAC LLC (U.S.), LG Electronics (South Korea), Emerson Electric Co. (U.S.), Trane (Ireland), SAMSUNG (South Korea) Pune, India, March 24, 2022 (GLOBE NEWSWIRE) — The heating, ventilation, and cooling (HVAC) system market size stood at USD 142.72 billion in 2021. The market is estimated to rise from USD 149.80 billion in 2022 to USD 215.23 billion by 2029 at a 5.3% CAGR during the forecast period. Fortune Business Insights™ has deep-dived into these insights in its latest research report, titled, “Heating, Ventilation, and Cooling (HVAC) System Market, 2022-2029.” According to the analysis, stakeholders have exhibited...

Gear Motor Market to Depict 4.2% CAGR from 2021 to 2028; Stakeholders to Explore Opportunities in Asia Pacific: Fortune Business Insights™

Written by Customer Service on March 24, 2022. Posted in Mergers And Acquisitions.

Companies Profiled in Gear Motor Market Siemens (Germany), Bonfiglioli (Italy), SEW Eurodrive (Germany), Nidec Motor Corporation (Japan), Bosch Rexroth (Germany), Eaton Corporation (Ireland), Regal Beloit Corporation (U.S.), Klingelnberg GmbH (Switzerland), Watt Drive Antriebstechnik GmbH (Germany), Emerson Electric Co. (U.S.), Elecon Engineering Co. Ltd (India), Brevini Power Transmission (Italy), Johnson Electric Holdings Limited (Hong Kong), Bauer Gear Motor GmbH (Germany), China High Speed Transmission Equipment Group Co., Ltd. (China) Pune, India, March 24, 2022 (GLOBE NEWSWIRE) — The global Gear Motor Market size was valued at USD 25.18 billion in 2020. The market is anticipated to rise from USD 26.78 billion in 2021 to USD 35.81 billion by 2028 at a 4.2% CAGR during the forecast period 2021-2028. Fortune Business Insights™...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals